NCT01711749 - Rosuvastatin Calcium Bioequivalence Study - Fast | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 25, 2013

Primary Completion Date

March 13, 2013

Study Completion Date

March 13, 2013

Conditions

Hypercholesterolaemia

Interventions

DRUG

Crestor®

Reference formulation is rosuvastatin calcium tablets, 20mg, currently commercialized by AstraZeneca do Brasil Ltda., under the trademark Crestor®

DRUG

rosuvastatin calcium tablets

Test formulation is rosuvastatin calcium tablets, 20 mg, produced by Laboratorios Phoenix S.A.I.C.F/Argentina for GlaxoSmithKline Brasil Ltda.

Trial Locations (1)

GSK Investigational Site, Bragança Paulista